Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-03-29
2011-03-29
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S350000
Reexamination Certificate
active
07914795
ABSTRACT:
The invention discloses theMoraxella catarrhalisouter membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses toM. catarrhalisandM. catarrhalisOMP106 polypeptides and OMP106-derived polypeptides in animals.
REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
patent: 5552146 (1996-09-01), Hansen et al.
patent: 5607846 (1997-03-01), Murphy et al.
patent: 5808024 (1998-09-01), Sasaki et al.
patent: 6335018 (2002-01-01), Sasaki et al.
patent: 6440424 (2002-08-01), Sasaki et al.
patent: 6440425 (2002-08-01), Sasaki et al.
patent: 6706269 (2004-03-01), Ruelle
patent: 6764834 (2004-07-01), Ruelle
patent: 7128910 (2006-10-01), Tucker et al.
patent: 7341727 (2008-03-01), Tucker et al.
patent: 93/03761 (1993-04-01), None
patent: 96/34960 (1996-11-01), None
Aebi et al., 1997, Infection & Immunity 65:4367-4377.
Bartos & Murphy, J. Infect. Dis. 158: 761-765 (1988).
Beck-Sickinger, et al., Epitope mapping: synthetic approaches to the understanding of molecular recognition in the immune system, Pharm Acta Helv., 68(1): 3-20 (1993).
Bogosian et al., Gene, 137: 17-22 (1993).
Brunham, et al., Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infectious Agents and Disease, 3 (5): 218 (1994).
Cain, et al., Solubilization of glycosyl-phosphatidylinositol-anchored proteins in quiescent and stimulated neutrophils, Biochim Biophys Acta., 1235(1): 69-78 (1995).
Chen et al., Infection and Immunity, 64(6): 1900-1905 (1996).
Corradin, Antigen processing and presentation, Immunol Lett, 25(1-3): 11-13 (1990).
Gu, et al., Infection and Immunity, 66(5): 1891-1897, May 1998.
Hays, et al, Total genome polymorphism and low frequency of intra-genomic variation in uspA1 and uspA2 genes ofMoraxella catarrhalisin otitis prone and non-prone children up to two years of age. Vaccine, 21: 1118 (2003).
Helminen et al., Infect. Immun., 61: 2003-2010 (1993).
Helminen et al., J. Infect. Dis., 170: 867-872 (1994).
Hu et al., Infection and Immunity, 68(9): 4980-4985 (2000).
Kellens et al., Infection, 23: 37-41 (1995).
Klingman & Murphy, Infect. Immun., 62: 1150-1155 (1994).
Kyd et al., Outer-membrane antigen expression byMoraxella(Branhamella)catarrhalisinfluences pulmonaryclearance, J. Med. Microbiol., 47: 159-168 (1998).
Kyd, et al., Vaccine, 18: 398-406 (2000).
Lane, et al., Epitope mapping using bacteriophage peptide libraries, Curr Opin Immunol 5(2): 268-71 (1993).
Mbaki et al., Tohuku J. Exp. Med., 153: 111-121 (1987).
Murphy & Bartos, Infect. Immun., 57: 2938-2941 (1989).
Murphy & Loeb, Microbial Pathogen, 6 159-174 (1989).
Murphy et al., Amer. J. Med., 88(5A): 41S-45S (1990).
Murphy et al., Molecul. Microbiol. 10: 87-97 (1993).
Nebl, et al., Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes, J. Bio Chem, 227(45): 43399-43409 (2002).
Poolman, Handb. Exp. Pharmacol., 133 (Vaccines) 235-248 (1999).
Rikitomi et al., Scand. J. Infect. Dis., 23: 559-567 (1999).
Samukawa et al., JID, 181: 1842-1845 (2000).
Sarwar et al., Infect. Immun., 60: 804-809 (1992).
Sasaki et al., Abstract of the 96.sup.th Gen Mtg of the Amer. Soc for Microbiol., May 19-27, 1996, B-181.
Sethl, et al., Antigenic heterogeneity and molecular analysis of CopB ofMoraxella(Brunharnella)catarrhalis. Infection and Immunity, 65(9): 3666 (1997).
Solo-Hernandez et al., J. Clin. Microbiol., 27: 903-908 (1989).
Tucker et al., Annual Meeting of Amer. Soc. Microbiol. Abstr. D124 (1994).
Unhanand et al., J. Infect. Dis. 165: 644-650 (1992).
Verduin et al., Abstr. Of the 95th Gen. Mtg. of the Amer. Soc. for Microbiol. p. 189 Abstr. B-137 (1995).
Vretou, et al., Identification of protective epitopes by sequencing of the Major Outer Membrane Protein gene of a variant strain of Chlamydia psittaci serotype 1. Infection and Immunity, 69(1): 607 (2001).
Westbay, et al., Dissociation of Immune determinants of Outer Membrane Proteins of Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Infection and Immunity, 62(12): 5614 (1994).
Zhang, et al., Comparison of the Major Outer Membrane Protein (MOMP) gene of mouse penumonitis (MoPn) and hamster SFPD strains of Chlamydia trachomatis with other Chlamydia strains, Mo. Biol. Evol., 10(6): 1327 (1993).
Harlow et al., Antibodies A laboratory Manual, Cold Spring Harbor Laboratory, p. 76 (1988).
Sigma Chemical Catalogue, p. 199 (1988).
Fitzgerald et al., FEMS Immunology and Medical Microbiology, 18: 209-216 (1997).
Forsgren et al., Infection and Immunity, 71(6): 3302-3309 (2003).
McGuinness et al., Mol. Microbiol., 7:505-514 (1993).
McGuinness et al., Lancet, 337:514-517 (1991).
Houghten et al., New Approaches to Immunization, Vaccines 86, Cold Spring Harbor Laboratory, p. 21-25 (1986).
Campbell, A.M., Monoclonal Antibody and Immunosensor Technology, Elsevier, pp. 1-7 (1991).
Harlow, “Antibodies, A Laboratory Manual”, Cold Spring Harbor Laboratory, pp. 55-61 (1988).
Aebi et al., “Phenotypic effect of isogenic uspA1 and uspA2 mutations onMoraxella catarrhalis035E”, Infection and Immunity, 66(7): 3113-9 (1998).
Plosila Laura
Tillman Ulrich F.
Tucker Kenneth
Emergent Product Development Gaithersburg Inc.
K&L Gates LLP
Navarro Mark
LandOfFree
Moraxella catarrhalis outer membrane protein-106... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Moraxella catarrhalis outer membrane protein-106..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Moraxella catarrhalis outer membrane protein-106... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2692356